Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...

IRFMN
SELEZIONE PUBBLICAZIONI SCIENTIFICHE APPARSE
NELL'ANNO 2007
Abdulla J, Barlera S, Latini R, Kjoller-Hansen L, Sogaard P, Christensen E, Kober L, Torp-Pedersen C
A systematic review: Effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection
fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction
Eur J Heart Fail 2007; 9: 129-135
Barlera S, Specchia C, Farrall M, Chiodini BD, Franzosi MG, Rust S, Green F, Nicolis E, Peden J, Assmann G,
Collins R, Hamsten A, Tognoni G, PROCARDIS Consortium
Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study
Eur J Hum Genet 2007; 15: 221-227
Boccanelli A, Cacciatore G, Mureddu GF, De Simone G, Clemenza F, De Maria R, Di Lenarda A, Gavazzi A, Latini
R, Masson S, Porcu M, Vanasia M, Gonzini L, Maggioni AP, AREA IN-CHF
Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone
Receptors Blockade with Canrenone in Mild Chronic Heart Failure)
J Cardiovasc Med 2007; 8: 683-691
Chiodini B, Franzosi MG, Barlera S, Signorini S, Lewis CM, D'Orazio A, Mocarelli P, Nicolis E, Marchioli R,
Tognoni G, GISSI, SIBioC-GISSI Prevenzione Group
Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a
Mediterranean population: the GISSI-Prevenzione study
Eur Heart J 2007; 28: 1977-1983
Cicoira M, Maggioni AP, Latini R, Barlera S, Carretta E, Janosi A, Soler Soler J, Anand I, Cohn J, Val-HeFT
Investigators
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure
Trial
Eur J Heart Fail 2007; 9: 397-402
Evangelista V, De Berardis G, Totani L, Avanzini F, Giorda CB, Brero L, Levantesi G, Marelli G, Pupillo M, Iacuitti
G, Pozzoli G, Di Summa P, Nada E, De Simone G, Dell'Elba G, Amore C, Manarini S, Pecce R, Maione A, Tognoni
G, Nicolucci A
Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin
J Thromb Haemost 2007; 5: 2197-2203
Fiordaliso F, De Angelis N, Bai A, Cuccovillo I, Salio M, Serra DM, Bianchi R, Razzetti R, Latini R, Masson S
Effect of Beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in
diabetic hypertensive rats
Life Sci 2007; 81: 951-959
Grasselli G, Gattinoni L, Kavanagh B, Latini R, Laupacis A, Lemaire F, Pesenti A, Suter P, Slutsky A, Tognoni G
Feasibility, limits and problems of clinical studies in Intensive Care Unit
Minerva Anestesiol 2007; 73: 595-601
Krum H, Latini R, Maggioni AP, Anand I, Masson S, Carretta E, Ingrilli' F, Pettinati G, Glazer R, Tognoni G, Cohn J
Statins and symptomatic chronic systolic heart failure. A post-hoc analysis of 5010 patients enrolled in Val-HeFT
Int J Cardiol 2007; 119: 48-53
Latini R, Masson S, Anand I S, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP,
Tognoni G, Cohn J N, Val-HeFT Investigators
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure
Circulation 2007; 116: 1242-1249
Sarto P, Balducci E, Balconi G, Fiordaliso F, Merlo L, Tuzzato G, Pappagallo GL, Frigato N, Zanocco A, Forestieri
C, Azzarello G, Mazzucco A, Valenti M T, Alborino F, Noventa D, Vinante O, Pascotto P, Sartore S, Dejana E,
Latini R
Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure
J Card Fail 2007; 13: 701-708
127
RAPPORTO ATTIVITA’ 2007